160 related articles for article (PubMed ID: 32610429)
21. Osteopontin level correlates with acute cellular renal allograft rejection.
Wang J; Tang Q; Qiu Y; Xu M; Rong R; Zhu T
J Surg Res; 2013 Jun; 182(1):161-5. PubMed ID: 22947699
[TBL] [Abstract][Full Text] [Related]
22. Kidney biomarkers in MCPA-induced acute kidney injury in rats: reduced clearance enhances early biomarker performance.
Wunnapuk K; Liu X; Gobe GC; Endre ZH; Peake PW; Grice JE; Roberts MS; Buckley NA
Toxicol Lett; 2014 Mar; 225(3):467-78. PubMed ID: 24480514
[TBL] [Abstract][Full Text] [Related]
23. [The clinical significance of serum and joint fluid osteopontin, and thrombin-cleaved osteopontin levels in osteoarthritis].
Dong X; Zheng Y; Liu HY
Zhonghua Nei Ke Za Zhi; 2013 Dec; 52(12):1023-7. PubMed ID: 24503399
[TBL] [Abstract][Full Text] [Related]
24. Elevated Levels of Galectin-9 but Not Osteopontin in HIV and Tuberculosis Infections Indicate Their Roles in Detecting MTB Infection in HIV Infected Individuals.
Shete A; Bichare S; Pujari V; Virkar R; Thakar M; Ghate M; Patil S; Vyakarnam A; Gangakhedkar R; Bai G; Niki T; Hattori T
Front Microbiol; 2020; 11():1685. PubMed ID: 32765475
[TBL] [Abstract][Full Text] [Related]
25. Renal biomarkers predict nephrotoxicity after paraquat.
Wunnapuk K; Liu X; Peake P; Gobe G; Endre Z; Grice JE; Roberts MS; Buckley NA
Toxicol Lett; 2013 Oct; 222(3):280-8. PubMed ID: 23954200
[TBL] [Abstract][Full Text] [Related]
26. Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease.
Lorenzen J; Krämer R; Kliem V; Bode-Boeger SM; Veldink H; Haller H; Fliser D; Kielstein JT
Eur J Clin Invest; 2010 Apr; 40(4):294-300. PubMed ID: 20486990
[TBL] [Abstract][Full Text] [Related]
27. Rapid decrease of plasma galectin-9 levels in patients with acute HIV infection after therapy.
Saitoh H; Ashino Y; Chagan-Yasutan H; Niki T; Hirashima M; Hattori T
Tohoku J Exp Med; 2012 Oct; 228(2):157-61. PubMed ID: 23038209
[TBL] [Abstract][Full Text] [Related]
28. Kidney injury molecule-1 and osteopontin: new markers for prediction of early kidney transplant rejection.
Jin ZK; Tian PX; Wang XZ; Xue WJ; Ding XM; Zheng J; Ding CG; Mao TC; Duan WL; Xi M
Mol Immunol; 2013 Jul; 54(3-4):457-64. PubMed ID: 23435265
[TBL] [Abstract][Full Text] [Related]
29. Equine urinary N-acetyl-β-D-glucosaminidase assay validation and correlation with other markers of kidney injury.
Bayless RL; Moore AR; Hassel DM; Byer BJ; Landolt GA; Nout-Lomas YS
J Vet Diagn Invest; 2019 Sep; 31(5):688-695. PubMed ID: 31347464
[TBL] [Abstract][Full Text] [Related]
30. Decrease in urinary creatinine in acute kidney injury influences diagnostic value of urinary biomarker-to-creatinine ratio in rats.
Tonomura Y; Uehara T; Yamamoto E; Torii M; Matsubara M
Toxicology; 2011 Dec; 290(2-3):241-8. PubMed ID: 22005293
[TBL] [Abstract][Full Text] [Related]
31. Early markers of renal dysfunction in patients with sickle cell/beta-thalassemia.
Voskaridou E; Terpos E; Michail S; Hantzi E; Anagnostopoulos A; Margeli A; Simirloglou D; Loukopoulos D; Papassotiriou I
Kidney Int; 2006 Jun; 69(11):2037-42. PubMed ID: 16501491
[TBL] [Abstract][Full Text] [Related]
32. Urinary, Plasma, and Serum Biomarkers' Utility for Predicting Acute Kidney Injury Associated With Cardiac Surgery in Adults: A Meta-analysis.
Ho J; Tangri N; Komenda P; Kaushal A; Sood M; Brar R; Gill K; Walker S; MacDonald K; Hiebert BM; Arora RC; Rigatto C
Am J Kidney Dis; 2015 Dec; 66(6):993-1005. PubMed ID: 26253993
[TBL] [Abstract][Full Text] [Related]
33. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
[TBL] [Abstract][Full Text] [Related]
34. Serial Quantification of Urinary Protein Biomarkers to Predict Drug-induced Acute Kidney Injury.
Da Y; Akalya K; Murali T; Vathsala A; Tan CS; Low S; Lim HN; Teo BW; Lau T; Ong L; Chua HR
Curr Drug Metab; 2019; 20(8):656-664. PubMed ID: 31296157
[TBL] [Abstract][Full Text] [Related]
35. Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old.
Van Den Noortgate NJ; Janssens WH; Delanghe JR; Afschrift MB; Lameire NH
J Am Geriatr Soc; 2002 Jul; 50(7):1278-82. PubMed ID: 12133025
[TBL] [Abstract][Full Text] [Related]
36. Osteopontin as a Biomarker in Chronic Kidney Disease.
Sinha SK; Mellody M; Carpio MB; Damoiseaux R; Nicholas SB
Biomedicines; 2023 May; 11(5):. PubMed ID: 37239027
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of Beta 2-Microglobulin, Cystatin C, and Lipocalin-2 as Renal Biomarkers for Patients with Fabry Disease.
Braga MC; Fonseca FLA; Marins MM; Gomes CP; Bacci MR; Martins AM; D'Almeida V
Nephron; 2019; 143(4):217-227. PubMed ID: 31216546
[TBL] [Abstract][Full Text] [Related]
38. Biomarkers upon discontinuation of renal replacement therapy predict 60-day survival and renal recovery in critically ill patients with acute kidney injury.
Yang T; Sun S; Zhao Y; Liu Q; Han M; Lin L; Su B; Huang S; Yang L
Hemodial Int; 2018 Jan; 22(1):56-65. PubMed ID: 28078828
[TBL] [Abstract][Full Text] [Related]
39. [Association between serum levels of osteopontin and systolic pulmonary artery pressure among healthy adults post acute high altitude exposure].
Yang YQ; Liu C; Yang J; Gao XB; Zhang JH; Shen Y; Huang L
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jun; 48(6):489-494. PubMed ID: 32842259
[No Abstract] [Full Text] [Related]
40. Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery.
Ristikankare A; Kuitunen T; Kuitunen A; Uotila L; Vento A; Suojaranta-Ylinen R; Salmenperä M; Pöyhiä R
Br J Anaesth; 2006 Nov; 97(5):611-6. PubMed ID: 16914459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
